| Journal | JMIR research protocols |
| Study Type | Systematic Review |
| Population | Human participants |
Arthritis patients frequently inquire about cannabis for pain management, yet most clinicians lack structured tools to facilitate evidence-based discussions. This protocol addresses a critical gap by developing a systematic framework for shared decision-making conversations about cannabis in arthritis care.
This multiphase study protocol outlines the development of a decision aid for older adults with arthritis considering medical cannabis, using established frameworks including the Ottawa Decision Support Framework and International Patient Decision Aids Standards. Phase 1 completed scoping reviews on shared decision-making tools and cannabis use in arthritis. The study aims to create a theory-driven, evidence-based tool that helps patients weigh cannabis benefits and risks according to their personal values and preferences. The protocol emphasizes user-centered design and systematic development methodology.
“Having these conversations without structured guidance often leaves both patients and clinicians unsatisfied. A well-designed decision aid could transform these discussions from anecdotal exchanges into evidence-informed collaborative decisions.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
- FAQ
- What is a decision aid for cannabis use in arthritis?
- Why do arthritis patients consider cannabis as a treatment option?
- Who is the target population for this cannabis decision aid?
- What frameworks guide the development of this decision aid?
- How does shared decision-making benefit cannabis treatment discussions?
FAQ
What is a decision aid for cannabis use in arthritis?
A decision aid is an evidence-based tool designed to help patients and healthcare providers engage in shared decision-making about cannabis use for arthritis management. It systematically presents potential benefits, risks, and considerations to support informed choices that align with individual patient values and preferences.
Why do arthritis patients consider cannabis as a treatment option?
Many arthritis patients turn to cannabis because conventional treatments often provide only partial relief for pain and related symptoms. This leads patients to seek alternative therapeutic options that may offer additional symptom management when standard treatments are insufficient.
Who is the target population for this cannabis decision aid?
The decision aid is specifically designed for older adults with arthritis who are considering medical cannabis as a treatment option. This population requires tailored information that considers age-related factors and the complexities of managing arthritis in geriatric patients.
What frameworks guide the development of this decision aid?
The development follows three established frameworks: the Ottawa Decision Support Framework, International Patient Decision Aids Standards, and User-Centeredness approach. These frameworks ensure the tool is theoretically grounded, meets quality standards, and is designed with patient needs at the center.
Shared decision-making allows patients to weigh potential cannabis benefits and risks in the context of their personal values, medical history, and treatment goals. This collaborative approach between patients and providers leads to more informed, personalized treatment decisions that patients are more likely to follow through with successfully.